Home / Product / Standard statistical products / Retail Audit of Drugs

RETAIL AUDIT OF DRUGS IN RUSSIA

• Methodology
• Regional scope
• Information sources
• Panel of pharmacies and data accuracy
• Selection of regions
• Pharmacy selection in each region
• Further data processing (extrapolation)
• Types of report
• Report information
• Format
• Frequency
• Features
• Regions included in the project "RETAIL AUDIT OF DRUGS IN RUSSIA"

Methodology

The research methodology is approved by the Association of International Pharmaceutical Manufacturers (AIPM).

In 2002 Deloitte & Touche audited the quality of "Retail Audit of Drugs in Russia" project and confirmed:
- the compliance of data obtaining and processing to the methodology
- the compliance of mathematical processing and extrapolation to stated parameters

The target of this project is to provide objective data on retail sales of drugs in the Russian Federation. The information in the database includes:

• sales volumes in value (retail prices and pharmacy purchasing prices)
• sales volumes in units
• average wholesale and retail prices
• manufacturer, INN, trade name, etc
• sales volumes in DDD (defined daily doses)
• market indicators - market share, sales increase, purchase index, etc

Regional scope

The 2007 panel covers over 4100 pharmacies - that is 7 % of the general universe.

The panel is sufficient for obtaining reliable data. By our estimates the error for Russia total equals 10%.

Information sources

Drug marketing records received directly from pharmacies are the reliable sources of information on retail sales. RMBC relies on bills-of-lading (nakladnie) submitted by pharmacies.

Panel of pharmacies and data accuracy

The highest level of accuracy of the analysis can be achieved only by including all of the existing stores into the panel, what is impossible to do in reality. That is why in order to provide the ultimate accuracy of the received data, a special panel is formed - a sample of pharmacies which corresponds to the existing pharmaceutical structure. The panel is formed through stratified random sampling and is not modified throughout the project period.

Selection of regions

The first step in forming the pharmacy panel was the selection of regions for monitoring. The regional selection methodology developed by RMBC consists in grouping all the 89 regions of the Russian Federation on the basis of certain macroeconomic factors (population income, welfare, etc.) and their geographical location. Selection of regions inside every group was carried out for the audit so that every group could be represented.

Pharmacy selection in each region

The next step after the selection of regions was forming a panel of pharmacies for each region. The panel represents the total pharmacy network, i.e. all types of pharmacies are included. In addition, the number of retail outlets is sufficient to avoid random mistakes.

Further data processing (extrapolation)

Further on the received data is applied to the whole market segment. This is called extrapolation. In terms of data processing extrapolation means that a "weight factor" (relative weight) is assigned to every retail outlet/region. When the final sales volume is calculated the 'weight factor' is multiplied by the sales figure (the sales volume of the outlet/region).

Types of report

• Russia total
• Moscow (by districts)
• 52 regions (cities/regions)

Report information:

• Product brand name
• Dosage form
• Manufacturer
• INN
• ATC code (5 levels)
• EphMRA code - European Pharmaceutical Market Research Association classification system
• Number of packs
• Retail prices
• Wholesale prices
• Average retail/wholesale prices
• Reference prices (the DLO)
• Regional prices (the DLO)
• DDD - Defined Daily Dose
• OTC/Rx
• Generic/original

Format

• Electronic version on CD (updated quarterly/monthly)
• Network/local version
• Russian/English language version

Frequency

Quarterly/monthly -1 month after the end of the reporting period.

Features

• volume of a market segment (in value and units)
• share of manufacturer in a market segment
• tracking the share of manufacturer in a market segment
• competitive analysis
• comparing prices for competing products
• import management based on the received data
• identifying segments with low competitive activity
• segment growth prospects in natural and in money terms
• other user-specified query information

Regions and cities included in the project "RETAIL AUDIT OF DRUGS IN RUSSIA" (updated quarterly/monthly)

1. Barnaul	27. Novosibirsk
2. Bashkortostan	28. Omsk region
3. Ufa	29. Omsk
4. Belgorod	30. Orenburg
5. Vladivostok	31. Penza
6. Vladimir	32. Perm
7. Voronezh region	33. Rostov region
8. Voronezh	34. Rostov-on-Don
9. Volgograd	35. Ryazan
10. Sverdlovsk region	36. Samara region
11. Yekaterinburg	37. Samara
12. Irkutsk	38. Saratov region
13. Kirov	39. Saratov
14. Krasnodar region	40. Smolensk
15. Krasnodar	41. Sochi
16. Krasnoyarsk region	42. Tatarstan
17. Krasnoyarsk	43. Kazan
18. Kursk	44. Tver
19. Leningrad region	45. Tyumen
20. St-Petersburg	46. Togliatti
21. Lipetsk	47. Tula
22. Moscow region	48. Khabarovsk
23. Moscow	49. Chelyabinsk
24. N.Novgorod region	50. Ulianovsk
25. N.Novgorod	51. Yaroslavl
26. Novosibirsk region	52. Ulan-Ude

Other: Bryansk, Makhachkala, Nalchik, Novokuznetsk, Kaluga, Kemerovo, Komsomolsk-on-Amur, Murmansk, Novgorod, Oryol, Pskov, Petrozavodsk, Izhevsk, Vladikavkaz, Stavropol, Tambov, Cheboksary, Chelyabinsk region